Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max Healthcare InstituteNSE:MAXHEALTH -0.76%93 Pretax Margin % is 21.68% as of Mar. 2026, which is 114% above its 10-year median of 10.14. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,431.48 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 664 Healthcare Providers & Services companies, Max Healthcare Institute ranks better than 89.61% on this metric.
The historical rank and industry rank for Max Healthcare Institute's Pretax Margin % or its related term are showing as below:
NSE:MAXHEALTH'
s Pretax Margin % Range Over the Past 10 Years
Min: -2.77 Med: 10.14 Max: 25.71
Current: 20.01
NSE:MAXHEALTH's Pretax Margin % is ranked better than 89.61% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs NSE:MAXHEALTH: 20.01
Max Healthcare Institute (NSE:MAXHEALTH) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Max Healthcare Institute Pretax Margin % Related Terms
Max Healthcare Institute Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAXHEALTH vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Max Healthcare Institute (NSE:MAXHEALTH) has a Pretax Margin % of 21.68% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Max Healthcare Institute and its competitors. This is 114% above median its historical median of 10.14. According to the industry distribution chart, Max Healthcare Institute ranks #69 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 10.4%.
Is Max Healthcare Institute's Pretax Margin % too high?
Max Healthcare Institute's current Pretax Margin % of 21.68% is 114% above median its 10-year median of 10.14. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. Max Healthcare Institute's value of 21.68% is 439.3% above this industry median. Based on the distribution chart, Max Healthcare Institute ranks #69 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #69 out of 664 companies for Pretax Margin %. This places Max Healthcare Institute in the top 10% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.02. Max Healthcare Institute's value of 21.68% is 439.3% above this benchmark. While the company's 10-year median is 10.14 vs. the industry median of 4.02, Max Healthcare Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current Pretax Margin % of 21.68% is 439.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Max Healthcare Institute and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current Pretax Margin % is 21.68%, which is 114% above median its own 10-year median of 10.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,431.48, compared to a current price of ₹1,089.90 — trading 23.9% below its estimated fair value. The current Pretax Margin % is 21.68%, which is 114% above median its 10-year median of 10.14 and 439.3% above the Healthcare Providers & Services industry median of 4.02. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current Pretax Margin % is 21.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,089.90 is trading 23.9% below its estimated GF Value™ of ₹1,431.48.
GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
Pretax Margin %: 21.68% (114% above median its 10-year median of 10.14)
GF Value™: ₹1,431.48 vs. price of ₹1,089.90 (23.9% below fair value)
Industry Position: 439.3% above the Healthcare Providers & Services median (#69 of 664)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score
Get the complete analysis for NSE:MAXHEALTH
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
